Skip to content
← Back to this collection

PUBLICATIONS · 27040279

Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Int J Hematol
Publication date
2016 Jul
First author
Morimoto A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Morimoto A
      type
      Author
    2. name
      Shioda Y
      type
      Author
    3. name
      Imamura T
      type
      Author
    4. name
      Kudo K
      type
      Author
    5. name
      Kawaguchi H
      type
      Author
    6. name
      Sakashita K
      type
      Author
    7. name
      Yasui M
      type
      Author
    8. name
      Koga Y
      type
      Author
    9. name
      Kobayashi R
      type
      Author
    10. name
      Ishii E
      type
      Author
    11. name
      Fujimoto J
      type
      Author
    12. name
      Horibe K
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Morimoto A
      type
      Author
    2. name
      Shioda Y
      type
      Author
    3. name
      Imamura T
      type
      Author
    4. name
      Kudo K
      type
      Author
    5. name
      Kawaguchi H
      type
      Author
    6. name
      Sakashita K
      type
      Author
    7. name
      Yasui M
      type
      Author
    8. name
      Koga Y
      type
      Author
    9. name
      Kobayashi R
      type
      Author
    10. name
      Ishii E
      type
      Author
    11. name
      Fujimoto J
      type
      Author
    12. name
      Horibe K
      type
      Author
    bibliography ids
    1. nci-bib-bf1cf4fc2ae46e5cf2d34de7
    book metadata
    content sha256
    94ab1fce86d19a747e9b608bc924cfe69b0a781ca08dc7acce4b5ee6643862e0
    document type
    citation
    dois
    1. 10.1007/s12185-016-1993-3
    electronic publication date
    display
    2016 Apr 4
    precision
    day
    year
    2016
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:27040279
    immutable id
    pubmed:27040279@94ab1fce86d19a747e9b608bc924cfe69b0a781ca08dc7acce4b5ee6643862e0
    journal
    abbreviation
    Int J Hematol
    issn electronic
    1865-3774
    issn print
    0925-5710
    issue
    1
    name
    International journal of hematology
    nlm unique id
    9111627
    pages
    99-109
    volume
    104
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      27040279
      provenance
      batch id
      fe5a46c92522c34737e8
      provider
      NCBI PubMed ESummary
      record sha256
      281d3d57d58ef6991500e05a11c59d9cc07ba70bf14a9180be6993d7fb7220a0
      response sha256
      2c7bacd02d2ece3813daf1a0f92260c22884bd9268942fcca2088ab229bfb4d1
      retrieved at
      2026-09-09T23:47:17.939307+00:00
      publication date
      display
      2016 Jul
      precision
      month
      year
      2016
      publication types
      1. Comparative Study
      2. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/27040279/
      title
      Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.

      Preserved source evidence · Not medical advice